ArticleScience advances2026
Real-time near-infrared II fluorescence navigation of magnetic nanorobots for image-guided therapy.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Task-Oriented Biomedical Microrobots: Access, Working Environment, Actuation, Body Design, Detection and Control.Micromachines · 2026Review
- Endothelial cell heterogeneity drives angiogenesis in endometriosis: mechanisms and emerging organoid-based models.Apoptosis : an international journal on programmed cell death · 2026Review
- In Vivo Microendoscopy in the Near-Infrared II Window.Small (Weinheim an der Bergstrasse, Germany) · 2026Article
- Kidney angiopoietin-like protein 4 regulates fibrotic responses in diabetic kidney disease.Frontiers in pharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Real-time navigation of nanorobots with high spatiotemporal resolution and molecular contrast in deep tissues via noninvasive manners has been challenging. Here, we developed near-infrared II (NIR-II; 1000 to 3000 nanometers) magnetic nanorobots that balance fluorescence brightness at ~1600 nanometers with magnetic strength, facilitating precise gathering or locomotion of the nanorobots in the peritoneal cavity, hindlimb, liver, spleen, and lower gastrointestinal tract of live mice under real-time NIR-II imaging guidance with high resolution and sensitivity. Two-plex NIR-II imaging enabled precise locomotion by simultaneously providing real-time information on both the location of nanorobots and the position of target sites with molecular specificity. NIR-II magnetic nanorobots remained stable in gastric juice simulated solution (pH = 2) for more than 2 weeks. The magnetic locomotion of nanorobots loaded with 5-aminosalicylic acid under NIR-II visual feedback enables targeted delivery to the lower gastrointestinal tract and effectively enhances therapeutic efficacy in mice with inflammatory bowel disease. This platform opens an avenue in precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.